Valeo Pharma Statistics
Valeo Pharma (VPHIF) Stock Statistics & Valuation Metrics
Total Valuation
Valeo Pharma has a market cap or net worth of $3.12M. The enterprise value is $71.50M.
- Market Cap
- $3.12M
- Enterprise Value
- $71.50M
Share Statistics
Valeo Pharma has 98,675,430 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 98,675,430
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Valeo Pharma’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
- Return on Equity (ROE)
- ―
- Return on Assets (ROA)
- ―
- Return on Invested Capital (ROIC)
- ―
- Return on Capital Employed (ROCE)
- ―
- Revenue Per Employee
- 770.14K
- Profits Per Employee
- -397.26K
- Employee Count
- 70
- Asset Turnover
- 1.31
- Inventory Turnover
- 3.99
Valuation Ratios
The current PE Ratio of Valeo Pharma is -0.21. Valeo Pharma’s PEG ratio is 0.07.
- PE Ratio
- -0.21
- PS Ratio
- 0.12
- PB Ratio
- -0.11
- Price to FCF
- -0.71
- Price to Operating Cash Flow
- -1.55
- PEG Ratio
- 0.07
Income Statement
In the last 12 months, Valeo Pharma had revenue of 53.91M and earned -27.81M in profits. Earnings per share was -0.32.
- Revenue
- 53.91M
- Gross Profit
- 13.08M
- Operating Income
- -17.23M
- Pretax Income
- -27.81M
- Net Income
- -27.81M
- EBITDA
- -11.39M
- Earnings Per Share (EPS)
- -0.32
Cash Flow
In the last 12 months, operating cash flow was -4.28M and capital expenditures -5.12M, giving a free cash flow of -9.40M billion.
- Operating Cash Flow
- -4.28M
- Free Cash Flow
- -9.40M
- Free Cash Flow per Share
- -0.10
Stock Price Statistics
- Beta
- -0.49
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.05
- 200-Day Moving Average
- 0.05
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Valeo Pharma upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- Sep 10, 2025
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Valeo Pharma as a current ratio of 1.25, with Debt / Equity ratio of -161.56%
- Current Ratio
- 1.25
- Quick Ratio
- 0.74
- Debt to Market Cap
- 5.09
- Net Debt to EBITDA
- ―
- Interest Coverage Ratio
- -1.25
Taxes
In the past 12 months, Valeo Pharma has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Balance Sheet
Valeo Pharma has $335.00K in cash and marketable securities with $1.00M in debt, giving a net cash position of -$666.00K billion.
- Cash & Marketable Securities
- $335.00K
- Total Debt
- $1.00M
- Net Cash
- -$666.00K
- Net Cash Per Share
- -$0.01
- Tangible Book Value Per Share
- -$0.07
Margins
Gross margin is 16.70%, with operating margin of -35.80%, and net profit margin of -60.18%.
- Gross Margin
- 16.70%
- Operating Margin
- -35.80%
- Pretax Margin
- -60.18%
- Net Profit Margin
- -60.18%
- EBITDA Margin
- -29.54%
- EBIT Margin
- -31.53%
